Bush Tia L
Insider CIK 1863418 · CNTA Chief Technology & Quality Ofc
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 125,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 140,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 360,338 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 145,208 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 27,187 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 140,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 147,954 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 35,000 | — | $0 | 147,954 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-02-01 | 2026-02-03 | 8,549 | $24.57 | $210.0K | 112,954 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-11-17 | 2025-11-18 | 40,000 | — | $0 | 360,338 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-11-17 | 2025-11-18 | 40,000 | $9.42 | $376.8K | 161,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-11-17 | 2025-11-18 | 40,000 | $28.00 | $1.12M | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-11-12 | 2025-11-13 | 40,000 | — | $0 | 400,338 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-11-12 | 2025-11-13 | 40,000 | $9.42 | $376.8K | 161,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-11-12 | 2025-11-13 | 40,000 | $26.00 | $1.04M | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-24 | 2025-09-24 | 35,000 | — | $0 | 440,338 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-24 | 2025-09-24 | 35,000 | $24.00 | $840.0K | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-24 | 2025-09-24 | 35,000 | $9.42 | $329.7K | 156,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-10 | 2025-09-11 | 25,000 | — | $0 | 475,338 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-10 | 2025-09-11 | 25,000 | $22.00 | $550.0K | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-10 | 2025-09-11 | 25,000 | $9.42 | $235.5K | 146,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-09 | 2025-09-11 | 24,792 | — | $0 | 145,208 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-09 | 2025-09-11 | 24,792 | $8.01 | $198.6K | 146,295 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-09 | 2025-09-11 | 24,792 | $20.00 | $495.8K | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-03 | 2025-02-04 | 11,000 | $16.86 | $185.5K | 121,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-02-01 | 2025-02-04 | 8,693 | $16.92 | $147.1K | 132,503 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-12-31 | 2024-12-31 | 6,419 | $16.35 | $105.0K | 141,196 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-17 | 2024-12-17 | 17,813 | — | $0 | 27,187 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-17 | 2024-12-17 | 17,813 | $3.85 | $68.6K | 165,428 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-17 | 2024-12-17 | 17,813 | $18.00 | $320.6K | 147,615 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-16 | 2024-12-17 | 9,611 | $16.36 | $157.2K | 147,615 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-09-30 | 2024-10-02 | 6,419 | $15.79 | $101.4K | 157,226 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-06-30 | 2024-07-02 | 6,419 | $9.03 | $58.0K | 163,645 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-03-31 | 2024-04-02 | 6,419 | $11.30 | $72.5K | 170,064 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-02-01 | 2024-02-02 | 170,000 | — | $0 | 170,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2024-02-01 | 2024-02-02 | 42,500 | — | $0 | 180,345 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-02-01 | 2024-02-02 | 3,862 | $8.19 | $31.6K | 176,483 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-12-31 | 2024-01-02 | 6,419 | $7.96 | $51.1K | 137,845 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-09-30 | 2023-10-03 | 6,419 | $6.47 | $41.5K | 144,264 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-06-30 | 2023-07-03 | 6,419 | $5.90 | $37.9K | 150,683 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2023-05-24 | 2023-05-26 | 5,000 | $4.49 | $22.4K | 3,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2023-05-24 | 2023-05-26 | 3,000 | $4.48 | $13.4K | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-03-31 | 2023-04-04 | 4,319 | $3.90 | $16.8K | 157,102 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-02-01 | 2023-02-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2023-02-01 | 2023-02-03 | 30,200 | — | $0 | 161,421 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-12-31 | 2023-01-04 | 3,014 | $3.10 | $9.3K | 136,986 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-10-03 | 2022-10-04 | 2,595 | $3.95 | $10.3K | 135,287 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-09-30 | 2023-01-13 | 5,765 | $4.25 | $24.5K | 134,235 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-09-30 | 2022-10-04 | 2,118 | $4.07 | $8.6K | 137,882 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2022-07-01 | 2022-07-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-02-01 | 2022-02-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-11-16 | 2021-11-18 | 4,005 | $12.55 | $50.3K | 8,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-11-16 | 2021-11-18 | 995 | $12.10 | $12.0K | 3,995 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-06-02 | 2021-06-04 | 3,000 | $20.00 | $60.0K | 3,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-05-07 | 2021-06-04 | 500,338 | — | $0 | 500,338 | SEC↗ |